Literature DB >> 10760696

Practical utility of the revised European-American classification of lymphoid neoplasms for Japanese non-Hodgkin's lymphomas.

T Izumo1, N Maseki, S Mori, E Tsuchiya.   

Abstract

A clinicopathological study of 515 non-Hodgkin's lymphoma (NHL) cases was performed using the revised European-American classification of lymphoid neoplasms (REAL classification) in an HTLV1-nonendemic area of Japan. The following characteristics were revealed: 1) frequency of extranodal lymphomas was high (59%) with 79% B-cell lymphomas in this series, while the overall ratio of B:T/NK lineage was 3.7:1; 2) the most common type was the diffuse large B-cell lymphoma (46%), follicle center lymphomas occurred at an incidence lower (15%) than that in European and American populations, and marginal zone B-cell lymphomas accounted for as much as 12%; 3) peripheral T-cell lymphomas were common (19%), with the unspecified type predominant (11%), while adult T-cell lymphomas were present at a level equivalent to that among European and American patients (1%). Clear segregation of survival curves was rated according to cell lineage and B-cell lymphomas had a better prognosis than T / NK-cell lymphomas. Furthermore, new subtypes in the REAL classification, such as marginal zone B-cell and mantle cell lymphomas, exhibited distinct curves. Taken altogether, the REAL classification demonstrated advantages for assessment of Japanese NHL cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760696      PMCID: PMC5926366          DOI: 10.1111/j.1349-7006.2000.tb00952.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  37 in total

1.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

Review 2.  Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.

Authors:  R J Lukes; J W Parker; C R Taylor; B H Tindle; A D Cramer; T L Lincoln
Journal:  Semin Hematol       Date:  1978-10       Impact factor: 3.851

3.  Nodal and extranodal malignant lymphoma in Israel: an epidemiological study.

Authors:  B Modan; M Shani; B Goldman; M Modan
Journal:  Br J Haematol       Date:  1969 Jan-Feb       Impact factor: 6.998

4.  The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.

Authors:  K P West; A Warford; L Fray; M Allen; A C Campbell; I Lauder
Journal:  J Pathol       Date:  1986-10       Impact factor: 7.996

Review 5.  Chromosome abnormalities in malignant lymphoma in patients from Saitama.

Authors:  N Maseki; Y Kaneko; M Sakurai; M Kurihara; K Sampi; K Shimamura; S Takayama
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

6.  Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases.

Authors:  J P Greer; J C York; J B Cousar; R T Mitchell; J M Flexner; R D Collins; R S Stein
Journal:  J Clin Oncol       Date:  1984-07       Impact factor: 44.544

7.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

Review 8.  Flow cytometric analysis of lymphomas.

Authors:  R C Braylan; N A Benson
Journal:  Arch Pathol Lab Med       Date:  1989-06       Impact factor: 5.534

9.  A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study.

Authors:  R I Fisher; S Dahlberg; B N Nathwani; P M Banks; T P Miller; T M Grogan
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

10.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

View more
  3 in total

1.  Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group.

Authors:  Ritsuko Seki; Koichi Ohshima; Koji Nagafuji; Tomoaki Fujisaki; Naokuni Uike; Fumio Kawano; Hisashi Gondo; Shigeyoshi Makino; Tetsuya Eto; Yukiyoshi Moriuchi; Fumihiro Taguchi; Tomohiko Kamimura; Hiroyuki Tsuda; Ryosuke Ogawa; Kazuya Shimoda; Kiyoshi Yamashita; Keiko Suzuki; Hitoshi Suzushima; Kunihiro Tsukazaki; Masakazu Higuchi; Atae Utsunomiya; Masahiro Iwahashi; Yutaka Imamura; Kazuo Tamura; Junji Suzumiya; Minoru Yoshida; Yasunobu Abe; Tadashi Matsumoto; Takashi Okamura
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

2.  Clinicopathological analysis of sinonasal malignant lymphoma in an HTLV-1 endemic area in Japan -special focus on primary sinonasal diffuse large B-cell lymphoma.

Authors:  Daisuke Murakami; Kaname Miyashita; Tetsuya Koyama; Hirofumi Omori; Yusuke Miyamoto; Motohiro Sawatsubashi; Takashi Nakagawa
Journal:  J Clin Exp Hematop       Date:  2019-08-08

3.  Significance of initial, interim and end-of-therapy 18F-FDG PET/CT for predicting transformation risk in follicular lymphoma.

Authors:  Mixue Xie; Lulu Wang; Qi Jiang; Xuxia Luo; Xin Zhao; Xueying Li; Jie Jin; Xiujin Ye; Kui Zhao
Journal:  Cancer Cell Int       Date:  2021-07-26       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.